Source:http://linkedlifedata.com/resource/pubmed/id/21430227
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003320,
umls-concept:C0012634,
umls-concept:C0026336,
umls-concept:C0039194,
umls-concept:C0085358,
umls-concept:C0205734,
umls-concept:C0254610,
umls-concept:C0332157,
umls-concept:C0962190,
umls-concept:C1149231,
umls-concept:C1332717,
umls-concept:C1334107,
umls-concept:C1367171,
umls-concept:C1413244,
umls-concept:C1416406,
umls-concept:C1423038,
umls-concept:C1522424,
umls-concept:C1524003,
umls-concept:C1553423,
umls-concept:C1706438,
umls-concept:C1762617,
umls-concept:C1831593,
umls-concept:C2698600
|
pubmed:issue |
9
|
pubmed:dateCreated |
2011-4-20
|
pubmed:abstractText |
Autoreactive CD8(+) T lymphocytes play a key role in the pathogenesis of several autoimmune diseases. It is not yet well understood how autoreactive CD8(+) T cells, which express TCRs with low reactivity toward self-Ags, gain the ability to respond to autoantigens to cause disease. Previously, we have shown that prior stimulation of CD8(+) T cells with synergistic combinations of cytokines produced by the innate immune response, such as IL-21 and IL-15, induces Ag-independent proliferation. Such "cytokine-primed" CD8 T cells displayed increased responsiveness to limiting quantities of the cognate Ag. In this paper, we report that prior stimulation with IL-15 and IL-21 also enables CD8(+) T cells to respond to weakly agonistic TCR ligands, resulting in proliferation, cytokine secretion, and cytolytic activity. Using a transgenic mouse model of autoimmune diabetes, we show that cytokine-primed autoreactive CD8(+) T cells induce disease following stimulation by weak TCR ligands, but their diabetogenic potential is dependent on continuous availability of IL-15 in vivo. These findings suggest that inflammatory cytokines could facilitate the triggering of autoreactive CD8(+) T cells by weak autoantigens, and this mechanism may have important implications for autoimmune diseases associated with microbial infections and chronic inflammation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Autoantigens,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-15,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-21
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1550-6606
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
186
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5131-41
|
pubmed:meshHeading |
pubmed-meshheading:21430227-Animals,
pubmed-meshheading:21430227-Autoantigens,
pubmed-meshheading:21430227-Autoimmunity,
pubmed-meshheading:21430227-CD8-Positive T-Lymphocytes,
pubmed-meshheading:21430227-Cell Separation,
pubmed-meshheading:21430227-Diabetes Mellitus, Type 1,
pubmed-meshheading:21430227-Disease Models, Animal,
pubmed-meshheading:21430227-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21430227-Flow Cytometry,
pubmed-meshheading:21430227-Interleukin-15,
pubmed-meshheading:21430227-Interleukins,
pubmed-meshheading:21430227-Lymphocyte Activation,
pubmed-meshheading:21430227-Mice,
pubmed-meshheading:21430227-Mice, Inbred C57BL,
pubmed-meshheading:21430227-Mice, Transgenic,
pubmed-meshheading:21430227-Receptors, Antigen, T-Cell
|
pubmed:year |
2011
|
pubmed:articleTitle |
Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
|
pubmed:affiliation |
Immunology Division, Department of Pediatrics, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada. Sheela.Ramanathan@Usherbrooke.ca
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|